253 related articles for article (PubMed ID: 20843586)
1. QSAR modeling, synthesis and bioassay of diverse leukemia RPMI-8226 cell line active agents.
Katritzky AR; Girgis AS; Slavov S; Tala SR; Stoyanova-Slavova I
Eur J Med Chem; 2010 Nov; 45(11):5183-99. PubMed ID: 20843586
[TBL] [Abstract][Full Text] [Related]
2. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of a new series of 4-chloro-2-mercapto-5-methylbenzenesulfonamide derivatives with potential antitumor activity.
Sławiński J
Eur J Med Chem; 2004 Feb; 39(2):179-88. PubMed ID: 14987826
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel 3-amino-2-(4-chloro-2-mercaptobenzenesulfonyl)-guanidine derivatives as potential antitumor agents.
Brzozowski Z; Saczewski F; Sławiński J
Eur J Med Chem; 2007 Sep; 42(9):1218-25. PubMed ID: 17337095
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity.
Havrylyuk D; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
J Med Chem; 2012 Oct; 55(20):8630-41. PubMed ID: 22992049
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel pyrazoles and pyrazolo[3,4-d]pyrimidines incorporating a benzenesulfonamide moiety.
Ashour HM; Wahab AE
Arch Pharm (Weinheim); 2009 Apr; 342(4):238-52. PubMed ID: 19340837
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.
El-Hawash SA; Wahab AE
Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, evaluation of anticancer activity and COMPARE analysis of N-bis(trifluoromethyl)alkyl-N'-substituted ureas with pharmacophoric moieties.
Luzina EL; Popov AV
Eur J Med Chem; 2012 Jul; 53():364-73. PubMed ID: 22538016
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of S-dialkylarsino-3-mercapto-1,2-propanediols and evaluation of their anticancer activity.
Gao M; Tan S; Chen Y; Zingaro RA
Bioorg Med Chem; 2007 Apr; 15(7):2660-6. PubMed ID: 17287125
[TBL] [Abstract][Full Text] [Related]
10. Novel 1,3,4-heterodiazole analogues: synthesis and in-vitro antitumor activity.
Taher AT; Georgey HH; El-Subbagh HI
Eur J Med Chem; 2012 Jan; 47(1):445-51. PubMed ID: 22119151
[TBL] [Abstract][Full Text] [Related]
11. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes.
Marx KA; O'Neil P; Hoffman P; Ujwal ML
J Chem Inf Comput Sci; 2003; 43(5):1652-67. PubMed ID: 14502500
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor evaluation of new polysubstituted thiazole and derived thiazolo[4, 5-d]pyrimidine systems.
Fahmy HT; Rostom SA; Bekhit AA
Arch Pharm (Weinheim); 2002 May; 335(5):213-22. PubMed ID: 12210778
[TBL] [Abstract][Full Text] [Related]
13. Use of Quantitative Structure-Activity Relationship (QSAR) and ADMET prediction studies as screening methods for design of benzyl urea derivatives for anti-cancer activity.
Lokwani D; Bhandari S; Pujari R; Shastri P; Shelke G; Pawar V
J Enzyme Inhib Med Chem; 2011 Jun; 26(3):319-31. PubMed ID: 20846089
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antitumor activity and QSAR studies of some 4-aminomethylidene derivatives of edaravone.
Marković V; Erić S; Juranić ZD; Stanojković T; Joksović L; Ranković B; Kosanić M; Joksović MD
Bioorg Chem; 2011 Feb; 39(1):18-27. PubMed ID: 21078519
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxicity of 2-acetyl-4,8-dihydrobenzodithiophene-4, 8-dione derivatives.
Chao YH; Kuo SC; Wu CH; Lee CY; Mauger A; Sun IC; Morris-Natschke SL; Lee KH
J Med Chem; 1998 Nov; 41(23):4658-61. PubMed ID: 9804705
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.
Sztanke K; Tuzimski T; Rzymowska J; Pasternak K; Kandefer-Szerszeń M
Eur J Med Chem; 2008 Feb; 43(2):404-19. PubMed ID: 17531354
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones.
Rathish IG; Javed K; Ahmad S; Bano S; Alam MS; Akhter M; Pillai KK; Ovais S; Samim M
Eur J Med Chem; 2012 Mar; 49():304-9. PubMed ID: 22305543
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I).
Caruso F; Rossi M; Tanski J; Pettinari C; Marchetti F
J Med Chem; 2003 Apr; 46(9):1737-42. PubMed ID: 12699391
[TBL] [Abstract][Full Text] [Related]
19. Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity.
Diana P; Martorana A; Barraja P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
Bioorg Med Chem; 2007 Jan; 15(1):343-9. PubMed ID: 17064918
[TBL] [Abstract][Full Text] [Related]
20. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065.
Sato A; McNulty L; Cox K; Kim S; Scott A; Daniell K; Summerville K; Price C; Hudson S; Kiakos K; Hartley JA; Asao T; Lee M
J Med Chem; 2005 Jun; 48(11):3903-18. PubMed ID: 15916443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
